X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with Abbott India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA ABBOTT INDIA PLETHICO PHARMA/
ABBOTT INDIA
 
P/E (TTM) x -1.1 32.9 - View Chart
P/BV x 0.0 8.2 0.2% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 PLETHICO PHARMA   ABBOTT INDIA
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
ABBOTT INDIA
Mar-16
PLETHICO PHARMA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs3956,015 6.6%   
Low Rs313,707 0.8%   
Sales per share (Unadj.) Rs604.41,236.9 48.9%  
Earnings per share (Unadj.) Rs32.5122.2 26.6%  
Cash flow per share (Unadj.) Rs51.3129.0 39.8%  
Dividends per share (Unadj.) Rs035.00 0.0%  
Dividend yield (eoy) %00.7 0.0%  
Book value per share (Unadj.) Rs473.6521.2 90.9%  
Shares outstanding (eoy) m34.0821.25 160.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.43.9 9.0%   
Avg P/E ratio x6.639.8 16.5%  
P/CF ratio (eoy) x4.237.7 11.0%  
Price / Book Value ratio x0.59.3 4.8%  
Dividend payout %028.6 0.0%   
Avg Mkt Cap Rs m7,262103,296 7.0%   
No. of employees `000NA3.0 0.0%   
Total wages/salary Rs m1,5963,370 47.4%   
Avg. sales/employee Rs ThNM8,891.8-  
Avg. wages/employee Rs ThNM1,140.0-  
Avg. net profit/employee Rs ThNM878.3-  
INCOME DATA
Net Sales Rs m20,59826,284 78.4%  
Other income Rs m386504 76.6%   
Total revenues Rs m20,98426,789 78.3%   
Gross profit Rs m2,8183,665 76.9%  
Depreciation Rs m642144 444.8%   
Interest Rs m1,5938 19,669.1%   
Profit before tax Rs m9694,017 24.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1381,421 -9.7%   
Profit after tax Rs m1,1072,596 42.6%  
Gross profit margin %13.713.9 98.1%  
Effective tax rate %-14.335.4 -40.4%   
Net profit margin %5.49.9 54.4%  
BALANCE SHEET DATA
Current assets Rs m18,87714,446 130.7%   
Current liabilities Rs m11,8964,725 251.8%   
Net working cap to sales %33.937.0 91.6%  
Current ratio x1.63.1 51.9%  
Inventory Days Days3651 69.9%  
Debtors Days Days19820 1,011.5%  
Net fixed assets Rs m9,8611,113 886.0%   
Share capital Rs m341213 160.3%   
"Free" reserves Rs m12,33110,808 114.1%   
Net worth Rs m16,13911,076 145.7%   
Long term debt Rs m4,7060-   
Total assets Rs m33,14616,241 204.1%  
Interest coverage x1.6497.0 0.3%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.61.6 38.4%   
Return on assets %8.116.0 50.8%  
Return on equity %6.923.4 29.3%  
Return on capital %12.336.3 33.8%  
Exports to sales %21.40.6 3,476.3%   
Imports to sales %15.212.6 120.4%   
Exports (fob) Rs m4,402162 2,724.3%   
Imports (cif) Rs m3,1363,322 94.4%   
Fx inflow Rs m4,402268 1,642.7%   
Fx outflow Rs m3,1843,927 81.1%   
Net fx Rs m1,219-3,659 -33.3%   
CASH FLOW
From Operations Rs m2,4372,514 96.9%  
From Investments Rs m-6,265-800 783.6%  
From Financial Activity Rs m2,490-803 -310.1%  
Net Cashflow Rs m-1,337912 -146.6%  

Share Holding

Indian Promoters % 82.7 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 4.3 7.9 54.4%  
FIIs % 5.5 0.1 5,500.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 17.1 43.9%  
Shareholders   10,665 18,270 58.4%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   CIPLA  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  SHASUN PHARMA  PFIZER  

Compare PLETHICO PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA - DR. REDDYS LAB COMPARISON

COMPARE PLETHICO PHARMA WITH

MARKET STATS